Enhanced Plaque Stabilization Effects of Alirocumab ― Insights From Artificial Intelligence-Aided Optical Coherence Tomography Analysis of the Alirocumab for Thin-Cap Fibroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography (ALTAIR) Study ―

Yamamoto et al. (Fri,) studied this question.

www.synapsesocial.com/papers/68e57c24b6db64358751b89a — DOI: https://doi.org/10.1253/circj.cj-24-0480

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome· 2018 · 3,451 citations
2. Reproducibility of an artificial intelligence optical coherence tomography software for tissue characterization: Implications for the design of longitudinal studies· 2023 · 7 citations
3. Reproducibility of In Vivo Measurements for Fibrous Cap Thickness and Lipid Arc by OCT· 2012 · 37 citations
4. Consensus Standards for Acquisition, Measurement, and Reporting of Intravascular Optical Coherence Tomography Studies· 2012 · 1,827 citations
5. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease· 2017 · 5,888 citations